To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Ketamine and magnesium significantly reduces morphine consumption in scoliosis patients

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2014

Ketamine and magnesium significantly reduces morphine consumption in scoliosis patients

Vol: 3| Issue: 8| Number:16| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Ketamine and magnesium association reduces morphine consumption after scoliosis surgery: prospective randomised double-blind study

Acta Anaesthesiol Scand. 2014 May;58(5):572-9

Contributing Authors:
HJ Jabbour NM Naccache RJ Jawish HA Abou Zeid KB Jabbour LG Rabbaa-Khabbaz IB Ghanem PH Yazbeck

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

78 patients, <18 years of age, diagnosed with idiopathic scoliosis and scheduled to receive posterior spinal fusion and instrumentation, were randomly assigned into 1 of 2 groups to discern the effect a combination of intravenous magnesium and ketamine had on morphine consumption during and after scoliosis surgery, when compared to the administration of ketamine alone. Patients received interventi...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue